Jonsson Comprehensive Cancer Center: Clinical Trials

403 trials sponsored by Jonsson Comprehensive Cancer Center, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

172 completed, 57 recruiting, 47 active not recruiting, 44 terminated. 155 Phase 2, 116 Phase 1, 85 Not applicable, 19 Early Phase 1, 19 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2155Completed 68, Recruiting 23, Active not recruiting 18, Withdrawn 16, Terminated 15, Unknown 12, Not yet recruiting 3
Phase 1116Completed 50, Terminated 16, Recruiting 14, Withdrawn 13, Active not recruiting 12, Unknown 9, Not yet recruiting 2
Not applicable85Completed 36, Recruiting 14, Active not recruiting 11, Terminated 8, Withdrawn 8, Not yet recruiting 4, Unknown 4
Early Phase 119Completed 9, Active not recruiting 4, Recruiting 3, Terminated 2, Withdrawn 1
Phase 319Completed 7, Unknown 5, Recruiting 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 42Completed 1, Recruiting 1

Follow Jonsson Comprehensive Cancer Center: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection
Biospecimen Collection, FDG-Positron Emission Tomography and Computed Tomography Scan, Ga-68 PET/CT Scan - Thyroid Gland Medullary Carcinoma
Not applicableNot yet recruitingJonsson Comprehensive Cancer Center1002027-09-022026-10-19
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Biospecimen Collection, Carboplatin, Computed Tomography - Lung Non-Squamous Non-Small Cell Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center162027-06-012026-02-05
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Biospecimen Collection, Computed Tomography, Elacestrant - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center502026-12-182026-06-09
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
Biospecimen Collection, Computed Tomography, Cyclophosphamide - Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 1Not yet recruitingJonsson Comprehensive Cancer Center202026-12-082026-07-20
Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial
Computed Tomography, Magnetic Resonance Imaging, MRI-guided Stereotactic Body Radiation Therapy - Metastatic Malignant Solid Neoplasm
Not applicableNot yet recruitingJonsson Comprehensive Cancer Center252026-12-012026-08-24
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Chemical Exchange Saturation Transfer Magnetic Resonance Imaging, Contrast-enhanced Magnetic Resonance Imaging, Magnetic Resonance Imaging - Glioblastoma
Phase 3Not yet recruitingJonsson Comprehensive Cancer Center602026-12-012026-07-07
A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer
Best Practice, Educational Intervention, Electronic Health Record Review - Skin Carcinoma
Not applicableNot yet recruitingJonsson Comprehensive Cancer Center602026-12-012026-07-01
Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Advanced Kidney Carcinoma, Advanced Renal Cell Carcinoma
Phase 1Not yet recruitingJonsson Comprehensive Cancer Center182026-12-012026-08-06
A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study
Non-Interventional Study - Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Not yet recruitingJonsson Comprehensive Cancer Center722026-12-012026-07-07
Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Atypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center352026-09-292026-05-06
Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial
Actigraphy, Biospecimen Collection, Educational Intervention - Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8
Not applicableNot yet recruitingJonsson Comprehensive Cancer Center202026-09-012026-05-11
RAD ONC FREEDOM Oncology Pain
Radiosurgery - Cancer Pain
Not applicableRecruitingJonsson Comprehensive Cancer Center192026-06-092026-07-08
AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
Biopsy Procedure, Cisplatin, Computed Tomography - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Cholangiocarcinoma
Phase 1RecruitingJonsson Comprehensive Cancer Center462026-05-292026-08-20
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
Abemaciclib, Biospecimen Collection, Imlunestrant - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2RecruitingJonsson Comprehensive Cancer Center422026-05-182026-08-20
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Biopsy Procedure, Biospecimen Collection, High-Dose Rate Brachytherapy - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Not applicableRecruitingJonsson Comprehensive Cancer Center452026-05-112026-05-22
Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Lung Non-Small Cell Carcinoma
Phase 2RecruitingJonsson Comprehensive Cancer Center602026-02-192026-04-20
Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
Virtual Reality (VR) Mindful App, Standard Calming Music - Breast Biopsy, Anxiety
Not applicableRecruitingJonsson Comprehensive Cancer Center6002026-01-202026-02-05
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
Neurovascular sparing stereotactic body radiation therapy - Prostate Cancer
Phase 3RecruitingJonsson Comprehensive Cancer Center2002025-12-162025-12-19
Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for the Treatment of Recurrent, Oligometastatic Prostate Adenocarcinoma
Actinium Ac 225 Vipivotide Tetraxetan, Biospecimen Collection, Gallium Ga 68 Gozetotide - Oligometastatic Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma
Phase 2RecruitingJonsson Comprehensive Cancer Center1072025-12-122026-09-17
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Biospecimen Collection, Computed Tomography Assisted Biopsy, Dapagliflozin Propanediol - Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8
Early Phase 1RecruitingJonsson Comprehensive Cancer Center482025-12-022026-02-19

Showing 20 of 403. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (70)  ·  Breast Neoplasms (41)  ·  Carcinoma, Non-Small-Cell Lung (30)  ·  Lung Neoplasms (29)  ·  Glioblastoma (27)  ·  Lymphoma (24)  ·  Lymphoma, Large B-Cell, Diffuse (20)  ·  Leukemia (19)  ·  Brain Neoplasms (17)  ·  Lymphoma, Follicular (17)  ·  Central Nervous System Neoplasms (16)  ·  Carcinoma, Renal Cell (15)  ·  Gliosarcoma (15)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (15)  ·  Melanoma (15)

Interventions

Magnetic Resonance Spectroscopy (59)  ·  Specimen Handling (32)  ·  Radiosurgery (18)  ·  gallium 68 PSMA-11 (14)  ·  68Ga-DKFZ-PSMA-11 (13)  ·  Carboplatin (13)  ·  Fluorodeoxyglucose F18 (13)  ·  Cyclophosphamide (12)  ·  Radiotherapy (12)  ·  Biopsy (10)  ·  Nivolumab (10)  ·  Temozolomide (10)  ·  fludarabine phosphate (10)  ·  pembrolizumab (10)  ·  Paclitaxel (9)

Countries

United States (377)  ·  Canada (4)  ·  United Kingdom (3)  ·  Australia (2)  ·  France (1)  ·  Germany (1)  ·  Sweden (1)

Top investigators

Christos E. Emmanouilides, MD (12)  ·  Jeremie Calais (9)  ·  Amar Kishan (8)  ·  Johannes Czernin, MD (8)  ·  John A. Glaspy, MD, MPH (7)  ·  Antoni Ribas, MD (6)  ·  Arie Belldegrun, MD, FACS (6)  ·  Carolyn Britten, MD (6)  ·  Gary J. Schiller, MD (6)  ·  Lee S. Rosen, MD (6)  ·  Mark D. Pegram, MD (6)  ·  Jeremie Calais, MD (5)  ·  Robert A. Figlin, MD, FACP (5)  ·  Caspian Oliai, MD (4)  ·  Charles Sawyers, MD (4)

Results publications

PMID 41698328, PMID 16775234, PMID 20856802, PMID 23377664, PMID 30573690, PMID 31375469, PMID 33602654, PMID 12622453, PMID 16061868, PMID 16568451, PMID 16710026, PMID 16740761, PMID 17317857, PMID 17560737, PMID 17947483, PMID 18215105, PMID 18708385, PMID 19015393, PMID 19170225, PMID 19299235, PMID 19536906, PMID 19770386, PMID 19811637, PMID 19877111, PMID 19914662, PMID 20676928, PMID 20688739, PMID 20864724, PMID 20875102, PMID 21111754, PMID 21558401, PMID 21703001, PMID 22244160, PMID 23519018, PMID 23595039, PMID 24442098, PMID 24708667, PMID 25545744, PMID 27282431, PMID 28434660, PMID 28468947, PMID 28473600, PMID 28669012, PMID 28948137, PMID 29242398, PMID 29242404, PMID 29470191, PMID 29590358, PMID 29874546, PMID 29899062

NIH funding

P30CA016042 (12), P50CA092131 (4), P50CA211015 (2), R01CA218547 (2), K08CA241337 (1), K08CA245181 (1), K08CA245249 (1), K12HD000850 (1), K76AG074918 (1), KL2TR001882 (1), M01RR000865 (1), P01CA168585 (1), P30CA006516 (1), P50CA086306 (1), P50CA089393 (1)